Advertisement

Topics

"EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease" Drugs and Medication Database

08:27 EDT 18th October 2018 | BioPortfolio

Here are the most relevant "EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease" Drugs and Medications that we have found in our database.

More Information about "EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease" on BioPortfolio

We have published hundreds of EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease news stories on BioPortfolio along with dozens of EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease Clinical Trials and PubMed Articles about EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease Companies in our database. You can also find out about relevant EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease Drugs and Medications on this site too.

Showing "EndocardialVascularEndothelialGrowth Factor VEGF Gene Therapy Treatment Severe Coronary" Drugs and Medications 1–25 of 258

Probably Relevant

Eylea [Regeneron Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection For Intravitreal Injection Initial U.S. Approval: 2011

Possibly Relevant

Lucentis [Genentech, Inc.]

These highlights do not include all the information needed to use LUCENTIS safely and effectively. See full prescribing information for LUCENTIS. LUCENTIS (ranibizumab injection)Intravitreal InjectionInitial U.S. Approval: 2006

Cholestyramine [Par Pharmaceutical, Inc. ]

Aceon [Abbott Products, Inc.]

These highlights do not include all the information needed to use ACEON safely and effectively. See full prescribing information for ACEON.ACEON (perindopril erbumine) 2, 4 and 8 mg Tablets Initial U.S. Approval: 1993

Perindopril erbumine [Roxane Laboratories, Inc.]

These highlights do not include all the information needed to use Perindopril Erbumine Tablets safely and effectively. See full prescribing information for Perindopril Erbumine Tablets. Perindopril Erbumine Tablets 2 mg, 4 mg and 8 mg Initial U.S. Approva

Hemofil m [Baxter Healthcare Corporation]

HEMOFIL M Antihemophilic Factor (Human)Method M, Monoclonal Purified

Atenolol [Aurobindo Pharma Limited]

Atenolol Tablets, USP

Metoprolol succinate [Med-Health Pharma, LLC]

Integrilin [Schering Corporation]

INTEGRILIN (eptifibatide) Injection

Lopid [Parke-Davis Div of Pfizer Inc]

LOPID (Gemfibrozil Tablets, USP)

R-gene [Pharmacia and Upjohn Company]

R-Gene 10Arginine Hydrochloride Injection, USP

Warfarin sodium [Physicians Total Care, Inc.]

Warfarin Sodium Tablets, USP

Warfarin sodium [Physicians Total Care, Inc.]

Warfarin Sodium Tablets, USP

Cholestyramine [Eon Labs, Inc.]

Cholestyramine for Oral Suspension USP

Cholestyramine [Upsher-Smith Laboratories, Inc.]

Cholestyramine for Oral Suspension, USP

Cholestyramine light [Eon Labs, Inc.]

Cholestyramine for Oral Suspension USP Light

Warfarin sodium [PD-Rx Pharmaceuticals, Inc.]

WARFARIN SODIUM TABLETS, USP

Warfarin sodium [Med Health Pharma, LLC]

WARFARIN SODIUM TABLETS, USP

Warfarin sodium [Rebel Distributors Corp]

Warfarin Sodium Tablets, USP

Erbitux [ImClone LLC]

These highlights do not include all the information needed to use ERBITUX safely and effectively. See full prescribing information for ERBITUX. ERBITUX (cetuximab)injection, for intravenous infusionInitial U.S. Approval: 2004

Kogenate fs [Bayer HealthCare LLC]

These highlights do not include all the information needed to use Kogenate FS safely and effectively. See full prescribing information for Kogenate FS.Initial U.S. Approval: 1993

4life enummi protective day moisturizer [4Life Research USA, LLC]

Drug Facts

Colestipol hydrochloride [Global Pharmaceuticals, Division of Impax Laboratories Inc.]

Colestipol Hydrochloride for Oral Suspension USP,5 grams/packet and 5 grams/scoopful

Kiss my face - face factor spf 30 [Kiss My Face Corp.]

Kiss My Face Face Factor SPF 30

Colestipol hydrochloride [Greenstone LLC]

Micronized Colestipol Hydrochloride Tablets



Advertisement
Quick Search
Advertisement
Advertisement